A phase I study evaluating the pharmacokinetics (PK) and pharmacodynamics (PD) of the oral pan-phosphoinositide-3 kinase (PI3K) inhibitor GDC-0941

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions